Literature DB >> 25878349

Unanticipated Multiplex PCR-Based Identification of Polymicrobial Blood Culture Resulting in Earlier Isolation, Determination of Susceptibilities, and Optimization of Clinical Care.

Tristan Timbrook1, M Sean Boger2, Lisa L Steed3, John M Hurst4.   

Abstract

We describe a case of polymicrobial bloodstream infection with six organisms identified by multiplex PCR that was initially thought to be a monomicrobial infection. Early recognition of specific Gram-positive, Gram-negative, and fungal organisms and resistance elements allowed significantly more rapid optimization of therapy.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25878349      PMCID: PMC4473190          DOI: 10.1128/JCM.00058-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures.

Authors:  Graeme N Forrest; Sanjay Mehta; Elizabeth Weekes; Durry P Lincalis; Jennifer K Johnson; Richard A Venezia
Journal:  J Antimicrob Chemother       Date:  2006-04-24       Impact factor: 5.790

2.  An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.

Authors:  Karri A Bauer; Jessica E West; Joan-Miquel Balada-Llasat; Preeti Pancholi; Kurt B Stevenson; Debra A Goff
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

3.  Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital.

Authors:  Peggy L Carver; Shu-Wen Lin; Daryl D DePestel; Duane W Newton
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

Review 4.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

5.  Evaluation of FilmArray and Verigene systems for rapid identification of positive blood cultures.

Authors:  M M Bhatti; S Boonlayangoor; K G Beavis; V Tesic
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

6.  Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Authors:  G N Forrest; K Mankes; M A Jabra-Rizk; E Weekes; J K Johnson; D P Lincalis; R A Venezia
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

7.  Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Authors:  Graeme N Forrest; Mary-Claire Roghmann; Latoya S Toombs; Jennifer K Johnson; Elizabeth Weekes; Durry P Lincalis; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

8.  Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.

Authors:  Barbara D Alexander; Elizabeth Dodds Ashley; L Barth Reller; Shelby D Reed
Journal:  Diagn Microbiol Infect Dis       Date:  2006-02-08       Impact factor: 2.803

9.  Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections.

Authors:  Emily L Heil; Lindsay M Daniels; Dustin M Long; Kyle G Rodino; David J Weber; Melissa B Miller
Journal:  Am J Health Syst Pharm       Date:  2012-11-01       Impact factor: 2.637

10.  Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis.

Authors:  Christine Dierkes; Boris Ehrenstein; Sylvia Siebig; Hans-Jörg Linde; Udo Reischl; Bernd Salzberger
Journal:  BMC Infect Dis       Date:  2009-08-11       Impact factor: 3.090

View more
  4 in total

1.  Evaluation of the Bruker® MBT Sepsityper IVD module for the identification of polymicrobial blood cultures with MALDI-TOF MS.

Authors:  Anaïs Scohy; Audrey Noël; Anca Boeras; Laetitia Brassinne; Terry Laurent; Hector Rodriguez-Villalobos; Alexia Verroken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-20       Impact factor: 3.267

Review 2.  Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis.

Authors:  Mariam Doualeh; Matthew Payne; Edward Litton; Edward Raby; Andrew Currie
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel.

Authors:  Karen C Carroll; Jennifer L Reid; Adam Thornberg; Natalie N Whitfield; Deirdre Trainor; Shawna Lewis; Teresa Wakefield; Thomas E Davis; Keisha G Church; Linoj Samuel; Ray Mills; Patricia Jim; Stephen Young; Frederick S Nolte
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

4.  Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections.

Authors:  Te-Din Huang; Ekaterina Melnik; Pierre Bogaerts; Stephanie Evrard; Youri Glupczynski
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.